HJ, J., G, U., AD, O., HJ, K., SA, N., AV, N., . . . PA, J. (2024). Bone marrow microenvironment signatures associate with patient survival after guadecitabine and atezolizumab therapy in HMA-resistant MDS. BioRxiv : the preprint server for biology. https://doi.org/10.1101/2024.11.08.622670
Chicago Style (17th ed.) CitationHJ, Jang, et al. "Bone Marrow Microenvironment Signatures Associate with Patient Survival After Guadecitabine and Atezolizumab Therapy in HMA-resistant MDS." BioRxiv : The Preprint Server for Biology 2024. https://doi.org/10.1101/2024.11.08.622670.
MLA (9th ed.) CitationHJ, Jang, et al. "Bone Marrow Microenvironment Signatures Associate with Patient Survival After Guadecitabine and Atezolizumab Therapy in HMA-resistant MDS." BioRxiv : The Preprint Server for Biology, 2024, https://doi.org/10.1101/2024.11.08.622670.